API CAS 461432-26-8 Dapagliflozin Material Dapagliflozin Powder Purity Dapagliflozin

• Powder: Yes
• Customized: Customized
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Adult
• State: Powder
• Purity: >99%
• Model NO.: D-sung Dapagliflozin
• Product Name: Dapagliflozin
• Name: Dapagliflozin Powder
• Appearance: White Powder
• Color: White
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Antidiabetic
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• CAS No.: 461432-26-8
• Mf: C21h25clo6
• MW: 408.875
• Boiling Point: 609°cat760mmhg
• Density: 1.349
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-sung
• Origin: Shaanxi Xi′an
• Production Capacity: 1000kg/Month

Product Description

Api CAS 461432-26-8 Dapagliflozin Material Dapagliflozin Powder Purity Dapagliflozin

Product Description

 

Product Details

Product name	Dapagliflozin
Appearance	White powder
CAS NO.	461432-26-8
MF	C21H25ClO6
MW	408.875

Dapagliflozin is a new type of antidiabetic drug jointly developed by Bristol-Myers Squibb and AstraZeneca. It was approved by the European Medicines Agency (EMA) on November 12, 2012 and is the first to be approved. SGLT2 inhibitors for the treatment of type 2 diabetes are important candidates for the treatment of diabetes. They are used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.

Application&Function

Dapagliflozin is a drug used to treat type 2 diabetes.It was developed by Bristol-Myers Squibb in partnership with AstraZeneca.Although dapagliflozin's method of action would operate on both types of diabetes and other conditions resulting in hyperglycemia, the current clinical trials specifically exclude participants with type 1 diabetes.

Specification